Increasing cancer screening rates in underserved neighborhoods
NYC Cancer Outreach Network in Neighborhoods for Equity and Community Translation Randomized Controlled Trial (NYC CONNECT)
This study is testing whether a more hands-on approach with community health workers can help people in underserved neighborhoods get important cancer screenings compared to just providing educational materials.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 2160 (estimated) |
| Ages | 21 Years to 75 Years |
| Sex | All |
| Sponsor | NYU Langone Health Academic / other |
| Locations | 2 sites (New York, New York and 1 other locations) |
| Trial ID | NCT05742178 on ClinicalTrials.gov |
What this trial studies
NYC CONNECT is a randomized controlled trial designed to evaluate the effectiveness of two strategies aimed at improving cancer screening rates for breast, cervical, and colorectal cancers. The trial compares a more intensive approach that includes culturally tailored educational materials and patient navigation services provided by community health workers against a less intensive approach that offers only the educational materials. Participants will be individuals due for cancer screenings, and all will receive assistance addressing unmet social determinants of health needs. The goal is to enhance access to necessary screenings in underserved communities.
Who should consider this trial
Good fit: Ideal candidates include women aged 21-75 and men aged 45-75 who are due for breast, cervical, or colorectal cancer screenings and reside in specific neighborhoods of New York City.
Not a fit: Patients who are already up-to-date with their cancer screenings or do not reside in the targeted neighborhoods may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly increase cancer screening rates among underserved populations, leading to earlier detection and better health outcomes.
How similar studies have performed: Other studies have shown success with community health worker interventions and culturally tailored educational approaches in increasing cancer screening rates, indicating a promising potential for this study.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women between the ages of 21 and 75 years; * Men between the ages of 45 and 75 years; * Women (40-74 years) who have not had a mammogram in the past 12 months, a Pap smear in the last 3 years (21-64 years old) or HPV test in the last 5 years (30-64 years old), or women 45-75 years old who are not up-to-date on colorectal cancer screening (Fecal occult blood test (FOBT)/Fecal immunochemical test (FIT) past year, computerized tomography (CT) colonography or sigmoidoscopy past 5 years, or colonoscopy past 10 years); * Men not up-to-date on colorectal cancer screening (FOBT/FIT past year, computerized tomography (CT) colonography or sigmoidoscopy past 5 years, or colonoscopy past 10 years); * Must speak either English, Spanish, Haitian-Creole, French, or Chinese (Mandarin and Cantonese); * Lives in East Flatbush (zip codes: 11236, 11203, 11212, 11226); Sunset Park (zip codes: 11215, 11220, 11232); Highbridge (zip code 10452, 10455, 10451); or Morrisania (zip codes: 10456, 10459) Exclusion Criteria: * Previous or current diagnosis of any cancer; * Pregnancy (breast and cervical cancer only); * Current participation in an existing cancer navigation program; * Currently in hospice care; * At least 66 years of age with advanced illness or frailty or who live in long-term institution for more than 90 days; * Bilateral mastectomy or right and left unilateral mastectomy (breast cancer only); * Hysterectomy with no residual cervix (cervical cancer only); * Total colectomy (colorectal cancer only).
Where this trial is running
New York, New York and 1 other locations
- NYU Langone Health — New York, New York, United States (Recruiting)
- Albert Einstein College of Medicine — The Bronx, New York, United States (Recruiting)
Study contacts
- Principal investigator: Chau Trinh, PhD — NYU Langone Health
- Study coordinator: Chau Trinh-Shevrin, DrPH
- Email: chau.trinh@nyulangone.org
- Phone: 646-501-3480
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.